Veltmeyer Institute for Advanced Therapeutics

Veltmeyer Institute for Advanced Biologics appears to be a private, California-based regenerative medicine organization launched in 2023 to provide patient access to investigational biologic therapies, particularly JadiCell adult stem cells, in applicable Right to Try settings. The entity is closely associated with Therapeutic Solutions International and was founded by Dr. James Veltmeyer, who has been described as the institute's founder and president. Publicly available information suggests the institute functions more as a treatment-access and clinical services organization than as an independent drug developer with its own disclosed pipeline. Reported focus areas include brain and lung disorders, end-stage disease, and regenerative medicine or immunotherapy approaches. The requested name "Veltmeyer Institute for Advanced Therapeutics" appears to refer to the same organization or an earlier/alternative naming used in collaboration announcements, but the formal launched entity name found in records is "Veltmeyer Institute for Advanced Biologics."